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Diarrheal diseases remain a major cause of mortality in Africa and worldwide. While the bur-
den of rotavirus is well described, population-based rates of disease caused by norovirus,
sapovirus, and astrovirus are lacking, particularly in developing countries.
Methods
Data on diarrhea cases were collected through a population-based surveillance platform
including healthcare encounters and household visits in Kenya. We analyzed data from
June 2007 to October 2008 in Lwak, a rural site in western Kenya, and from October 2006
to February 2009 in Kibera, an urban slum. Stool specimens from diarrhea cases of all ages
who visited study clinics were tested for norovirus, sapovirus, and astrovirus by RT-PCR.
Results
Of 334 stool specimens from Lwak and 524 from Kibera, 85 (25%) and 159 (30%) were pos-
itive for norovirus, 13 (4%) and 31 (6%) for sapovirus, and 28 (8%) and 18 (3%) for astro-
virus, respectively. Among norovirus-positive specimens, genogroup II predominated in
both sites, detected in 74 (87%) in Lwak and 140 (88%) in Kibera. The adjusted community
incidence per 100,000 person-years was the highest for norovirus (Lwak: 9,635; Kibera:
4,116), followed by astrovirus (Lwak: 3,051; Kibera: 440) and sapovirus (Lwak: 1,445;
Kibera: 879). For all viruses, the adjusted incidence was higher among children aged <5
years (norovirus: 22,225 in Lwak and 17,511 in Kibera; sapovirus: 5,556 in Lwak and 4,378
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years.
Conclusion
Although limited by a lack of controls, this is the first study to estimate the outpatient and
community incidence rates of norovirus, sapovirus, and astrovirus across the age spectrum
in Kenya, suggesting a substantial disease burden imposed by these viruses. By applying
adjusted rates, we estimate approximately 2.8–3.3 million, 0.45–0.54 million, and 0.77–0.95
million people become ill with norovirus, sapovirus, and astrovirus, respectively, every year
in Kenya.
Introduction
Although global deaths from diarrheal disease have decreased from 2.6 million to 1.3 million
between 1990 and 2013 [1], it remains a major health concern, particularly in Africa. Diarrheal
illness was estimated to be one of the top causes of years of life lost in sub-Saharan Africa in
2013, along with HIV/AIDS, lower respiratory infections, and malaria [1]. Young children are
known to be the most affected population, and there were an estimated 450 million diarrheal
episodes among children<5 years of age in 2010 in Africa [2]. The burden of rotavirus, which
remains the leading cause of severe diarrheal disease in children worldwide, has been well char-
acterized in both developed and developing countries [3–8]. Although norovirus, sapovirus,
and astrovirus are also recognized as contributors to diarrheal disease [9], population-based
rates of disease associated with these viruses are not available in sub-Saharan African countries.
With the expected decline of rotavirus disease after vaccine implementation [10–13], monitor-
ing for other diarrheal pathogens will be important to assess changes in their relative burden in
order to implement appropriate public health measures, especially in regions with high inci-
dence of diarrheal diseases.
To help fill this gap, we aimed to estimate population-based rates of diarrheal illness associ-
ated with norovirus, sapovirus, and astrovirus in Kenya. We used a unique active surveillance
system for infectious disease syndromes implemented by the Kenya Medical Research Institute
(KEMRI) and the United States Centers for Disease Control and Prevention (CDC) to achieve
this goal.
Materials and Methods
Population-based infectious disease surveillance
The population-based infectious disease surveillance (PBIDS) system was launched in late
2005 by CDC and KEMRI. The system encompassed two sites in Kenya: Lwak and Kibera (Fig
1). Lwak is a rural location in Nyanza province (current Kisumu Country) near Lake Victoria
in Western Kenya, which is one of the poorest areas in the country. Kibera is an urban slum in
Nairobi, which is the capital and the largest city in Kenya. The geographic characteristics of
these surveillance areas have been described previously [14, 15]. The study periods for this
analysis was from June 2007 to October 2008 (one year and five months) in Lwak and from
October 2006 to February 2009 (two years and five months) in Kibera.
The PBIDS system has been described in detail [15]. Briefly, it targets infectious disease syn-
dromes, such as diarrheal disease, febrile illness, pneumonia, and jaundice. All residents of all
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ages in both surveillance sites were eligible for enrollment, as long as they had lived in the
region for more than four consecutive months during the study period. Neonates born to a
mother enrolled in PBIDS were also offered enrollment.
One unique aspect of the PBIDS system is that it includes both household surveillance and
clinic surveillance. In the household surveillance, trained community interviewers visited all
enrolled household every two weeks and asked participants about illnesses and deaths that
Fig 1. Map of the study sites in Kenya.
doi:10.1371/journal.pone.0145943.g001
Norovirus, Sapovirus, and Astrovirus in Kenya
PLOS ONE | DOI:10.1371/journal.pone.0145943 April 26, 2016 3 / 20
occurred since the last visit using standardized questionnaires. If a participant was absent or
unable to answer the questions, a proxy who had the information of the participant’s health
was interviewed. Mothers or other primary caretakers were interviewed if children were not
able to answer the questions. Community interviewers also conducted focused physical exams
on sick participants during the visit. The exam consisted of measuring axillary temperature
and respiratory rate, evaluating for signs of respiratory distress in ill children, and observing
signs of dehydration. For the clinic surveillance, a centrally located health care facility was iden-
tified in each study site, which was located within 5 km or 1 km of all people living in Lwak and
Kibera, respectively. All surveillance participants received free medical care at these study clin-
ics for all acute infectious conditions. Detailed information was collected for all sick visits using
structured questionnaires and specimens were collected from patients meeting case definitions
(see below).
Specimen collection and diagnostics
At the study clinics, stool specimens were collected from consenting patients of all ages who
met at least one of three criteria. The first criterion was uncomplicated diarrhea, which was
defined as three or more loose stools within a 24-hour period, without signs or symptoms of
dehydration or dysentery. Because there were many patients meeting this criterion, a maxi-
mum of six stool specimens were collected from patients with uncomplicated diarrhea per day
in each study site: three from patients5 years of age and three from patients<5 years of age.
The second criterion was having complicated diarrhea based on the presence of signs and
symptoms of dehydration, which was defined as drinking eagerly, being unable to drink or
breastfeed, emesis, slow capillary refill (two seconds or more), irritability, sunken eyes, lethargy
or unconsciousness. In this group, stool specimens were attempted to be collected from all con-
senting patients. The third criterion was having dysentery, which was defined as reported or
visible blood in one or more stool within 24 hours of clinic visit. We aimed to collect stool spec-
imens from all patients meeting this criterion. If participants were unable to produce stool at
the clinic, patients were sent home with stool cups and instructions, and stool specimens were
collected from their homes within four hours of clinic visits.
The stool specimens were aliquoted at KEMRI-CDC laboratories in Kenya and stored at
−80°C and then an aliquot from each patient was batch shipped to the CDC laboratory in
Atlanta, Georgia, on dry ice to test for norovirus, sapovirus, and astrovirus. Viral nucleic acid
was extracted from stool suspensions according to the MagMAX-96 Viral RNA Isolation KIT
protocol (Ambion, Austin, Texas) on the KingFisher instrument (Thermo Scientific, Vantaa,
Finland). Viral nucleic acid was then tested for norovirus genogroup I and II, sapovirus, and
astrovirus using TaqMan real-time reverse-transcription polymerase chain reaction (RT-
qPCR) [16–20].
In addition to these three enteric viruses, stool specimens were tested for rotavirus using a
commercially available enzyme immunoassay kit (Rotaclone, Meridian Premier, Charlotte,
North Carolina), as previously described [21], and were cultured for Salmonella, Shigella, Cam-
pylobacter, and Vibrio species by standard techniques [22].
Analysis of incidence
Data were analyzed using SAS, version 9.3 (SAS Institute, Cary, North Carolina). Crude inci-
dence was calculated as the number of diarrheal illness episodes with stool specimens testing
positive for norovirus, sapovirus, or astrovirus among PBIDS participants per 100,000 partici-
pant person-years of observation (PYO). If a patient experienced multiple episodes of diarrhea
more than 14 days apart from each other, we considered them as unique episodes and counted
Norovirus, Sapovirus, and Astrovirus in Kenya
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them separately in the numerator. PYO was calculated by dividing the sum of person-days for
all participants who met the surveillance inclusion criteria by 365.25. A participant who moved
away from the surveillance area for longer than four consecutive months was not counted in
the denominator for calculation of PYO during or after the leave. If that person returned to the
surveillance area, he/she was not counted in denominator or numerator until confirmed to be
living in the surveillance area for at least four consecutive months and re-consented to partici-
pate in the study.
To assess the seasonality of norovirus, sapovirus, and astrovirus-associated diarrheal ill-
nesses, we calculated annualized crude incidence rates in each month as follows:
Annualized crude incidence per 100; 000 PYO in each month ¼
Average number of positive specimens in each month
PYO
 12 100; 000
In order to estimate incidence of the viral diarrhea cases at the outpatient and community
levels, we applied three adjustment factors to the crude incidence rates to account for the
potentially undetected cases at the study clinics. The first adjustment factor was the proportion
of patients whose stool specimens were submitted and tested among all diarrhea cases meeting
stool-sampling criteria (PSS). This factor accounted for patients who visited the study clinics
and met the stool specimen collection criteria, but did not provide a specimen, and patients
whose specimens were excluded due to technical issues. The formula below shows how we cal-
culated the adjusted incidence at the study clinic:
Study clinic incidence ¼ Crude incidence
PSS
The second adjustment factor was the proportion of diarrhea patients who visited the study
clinic among diarrhea patients who visited any clinics including non-study clinics (PSC). The
denominator of this proportion was obtained from the household surveillance, which detected
diarrhea patients who visited non-study clinics. The outpatient incidence was calculated as fol-
lows:
Outpatient incidence ¼ Crude incidence
PSS  PSC
The third adjustment factor was the proportion of diarrhea patients who visited any clinic
among all diarrhea patients identified in the community, including those who did not seek
medical care (PMC). The household surveillance data enabled us to detect all diarrhea patients
in the study sites, and collect information as to whether they accessed any clinic, the determi-
nants of which include a variety of factors. For example, the symptoms were not severe enough
to warrant a clinic visit, or simply people made a decision about accessing (or was able to
access) a clinic, which may have been unrelated to illness severity. The community incidence
was defined as follows:
Community incidence ¼ Crude incidence
PSS  PSC  PMC
These adjusted incidence rates and their respective 95% credible intervals (CI) were com-
puted using Monte Carlo simulation. We constructed a normal distribution around each of
three adjustment factors based on their numerators and denominators, and randomly selected
one value from each of the distributions. The crude incidence rates were then divided by these
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selected values. This process was repeated 100,000 times and the median was reported as the
point estimate of adjusted incidence and 2.5th and 97.5th percentile as the 95% CI.
Ethical approvals
Written informed consent was obtained for data collection at the clinics and households. The
protocol, surveillance questionnaires and consent forms were reviewed and approved by the
Ethical Review Committee at KEMRI (protocol number 932 and 1899) and the Institutional
Review Board of CDC-Atlanta (protocol number 4566).
Results
Characteristics of the study population
The patients of this study submitted a total of 336 and 558 stool specimens in Lwak and Kibera,
respectively, during the study periods. In Lwak, two stool specimens were excluded from analy-
sis, because these specimens were collected within 14 days since the collection of the initial
specimens from the same patients and, thus, considered part of the same episode. In Kibera, a
total of 34 stool specimens were excluded from the analysis; 33 were excluded because of miss-
ing date of birth, date of specimen collection, or patient ID number, and one was excluded
because it was collected within 14 days of another specimen from the same patient. Thus, a
total of 334 and 524 stool specimens representing unique episodes of diarrhea were included in
the analysis in Lwak and Kibera, respectively. Of these, 18 and 27 patients experienced more
than one unique episode of diarrhea during the study periods in Lwak and Kibera, respectively.
Both genders were well represented among the study populations in both sites; 155 (46%)
and 257 (49%) episodes of diarrhea were observed among males in Lwak and Kibera, respec-
tively. The surveillance participants in Lwak were older (median age 27.0 years, range 0–85
years) than Kibera (median age 9.6 years, range 0–67 years). Children<5 years of age repre-
sented 19% of the study population in Lwak and 40% in Kibera.
Prevalence of enteric pathogens
In both study sites, norovirus was the most common etiology, detected in 85 (25%) of 334 spec-
imens in Lwak and 159 (30%) of 524 specimens in Kibera (Table 1). Among norovirus positive
specimens, genogroup (G) II predominated in both sites, detected in 74 (87%) in Lwak and 140
(88%) in Kibera. Coinfection with GI and GII was found in 6 (7%) norovirus-positive speci-
mens in Lwak and 14 (9%) in Kibera. Overall, the prevalence of sapovirus and astrovirus was
low (3–8%) in both study sites. Sapovirus was more prevalent than astrovirus in Kibera, while
the opposite was found in Lwak. All viruses were more frequently detected among diarrhea
patients aged<5 years compared to those5 years of age in Kibera (p<0.05). The same trend
was observed in Lwak, but the difference between the two age groups was not statistically
significant.
As shown in Table 2, 311 specimens were positive for at least one of norovirus, sapovirus, or
astrovirus. Of these, 28 (9%) and 82 (26%) also tested positive for rotavirus and bacteria,
respectively. The proportion of rotavirus coinfection was the highest among patients with com-
plicated diarrhea (9/50, 18%), while coinfection with bacteria occurred most frequently among
patients with dysentery (40/84, 48%). Among the 82 specimens in which coinfections of bacte-
ria and at least one of norovirus, sapovirus, or astrovirus were found, Shigella spp. (n = 65,
79%) were most frequently identified, followed by Campylobacter spp. (n = 9, 11%), and Salmo-
nella spp. (n = 7, 9%). Given the potential for asymptomatic (i.e., non-etiologic) detection of
Norovirus, Sapovirus, and Astrovirus in Kenya
PLOS ONE | DOI:10.1371/journal.pone.0145943 April 26, 2016 6 / 20
norovirus, sapovirus, and astrovirus, we excluded stool specimens from the numerator of
crude incidence calculation if they were coinfected with rotavirus and/or bacteria.
Clinical profile of norovirus, sapovirus, and astrovirus
The patients with multiple enteric viruses were excluded from the analysis of the clinical profile
of norovirus, sapovirus, and astrovirus infections. Uncomplicated diarrhea was most com-
monly observed among the three types of diarrhea used as the stool collection criteria, followed
by dysentery (Table 3). The majority of patients had 3–10 loose stools per day for 1–4 days,
regardless of etiology. Vomiting and fever (temperature greater than 37.0°C) were observed in
less than half of the patients. No significant difference in clinical profile was observed among
the three different viral etiologies.
Crude and adjusted incidence of diarrheal illness
The overall crude incidence rates of norovirus, sapovirus, and astrovirus-associated diarrheal
illnesses were 187, 28, and 59 per 100,000 PYO in Lwak (Table 4) and 184, 39, and 20 per
100,000 PYO in Kibera (Table 5). The crude incidence rates of all viruses were the highest
among children<12 months of age in both sites. As shown in Fig 2, there was no clear season-
ality of crude incidence rates of diarrheal illness associated with these enteric viruses. The
annualized crude incidence of norovirus and astrovirus exhibited a large peak in November






















27 1 (4) 9 (33) 10 (37) 2 (7) 5 (19) 43 6 (14) 16 (37) 20 (47) 7 (16) 5 (12)
12–23
months
20 2 (10) 4 (20) 6 (30) 0 (0) 2 (10) 52 5 (10) 15 (29) 16 (31) 4 (8) 5 (10)
24–59
months
17 0 (0) 5 (29) 5 (29) 1 (6) 1 (6) 114 7 (6) 40 (35) 42 (37) 11 (10) 4 (4)
5–9
years
19 2 (11) 4 (21) 5 (26) 0 (0) 4 (21) 57 3 (5) 13 (23) 16 (28) 5 (9) 2 (4)
10–17
years
40 0 (0) 9 (23) 9 (23) 1 (3) 2 (5) 32 0 (0) 11 (34) 11 (34) 0 (0) 0 (0)
18–34
years
98 7 (7) 20 (20) 25 (26) 8 (8) 6 (6) 149 8 (5) 34 (23) 40 (27) 3 (2) 1 (1)
35–49
years
59 5 (8) 14 (24) 16 (27) 1 (2) 4 (7) 60 4 (7) 8 (13) 11 (18) 1 (2) 0 (0)
50
years
54 0 (0) 9 (17) 9 (17) 0 (0) 4 (7) 17 0 (0) 3 (18) 3 (18) 0 (0) 1 (6)
Gender,
no. (%)
Male 155 5 (3) 42 (27) 46 (30) 7 (5) 10 (6) 257 14 (5) 65 (25) 72 (28) 17 (7) 7 (3)
Female 179 12 (7) 32 (18) 39 (22) 6 (3) 18 (10) 267 19 (7) 75 (28) 87 (33) 14 (5) 11 (4)
Total,
no. (%)
334 17 (5) 74 (22) 85 (25) 13 (4) 28 (8) 524 33 (6) 140 (27) 159 (30) 31 (6) 18 (3)
NoV GI: norovirus genogroup I; NoV GII: norovirus genogroup II; +: positive.
doi:10.1371/journal.pone.0145943.t001
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and April, respectively, in Lwak, but a similar trend by month was not observed in Kibera. The
annualized crude incidence of sapovirus was low throughout the year in both sites.
The proportion of diarrhea patients with a stool specimen (PSS) was low in both sites (14%
in Lwak and 12% in Kibera), and appeared to be even lower among younger children (Tables 4
and 5). About half (53%) of the patients who sought medical attention in Lwak and 80% of
them in Kibera presented at the study clinics (PSC). After adjusting the crude incidence rates by
PSS and PSC, the overall outpatient incidence rates of norovirus, sapovirus, and astrovirus-asso-
ciated diarrheal illnesses became 2,619, 393, and 829 per 100,000 PYO in Lwak and 1,937, 414,
and 207 per 100,000 PYO in Kibera. In both sites, norovirus was the most prevalent among all
age groups. The highest outpatient incidence rates for all viruses detected were observed
among children<12 months of age (Fig 3A). The outpatient incidence associated with detec-
tion of norovirus decreased by 17% in Lwak and 62% in Kibera in children 12–23 months of
age compared to children<12 months of age.
Table 2. Detection of enteric pathogens stratified by stool specimen collection criteria, Kenya.
Uncomplicated diarrheaa Complicated diarrheab Dysenteryc
(n = 483) (n = 101) (n = 274)
Single infection, no. (%)
NoV 102 (21) 23 (23) 31 (11)
SaV 9 (2) 4 (4) 7 (3)
HAstV 12 (2) 6 (6) 4 (1)
RV 20 (4) 4 (4) 5 (2)
Bacteria 71 (15) 11 (11) 76 (28)
Coinfection, no. (%)
NoV + RV 6 (1) 5 (5) 1 (0)
NoV + Bacteria 25 (5) 2 (2) 24 (9)
NoV + RV + Bacteria 3 (1) 2 (2) 4 (1)
NoV + SaV 4 (1) 0 (0) 0 (0)
NoV + SaV + RV 0 (0) 1 (1) 0 (0)
NoV + SaV + Bacteria 1 (0) 1 (1) 1 (0)
NoV + SaV + HAstV 0 (0) 1 (1) 1 (0)
NoV + HAstV 0 (0) 1 (1) 0 (0)
NoV + HAstV + RV 2 (0) 1 (1) 0 (0)
NoV + HAstV + Bacteria 1 (0) 0 (0) 1 (0)
SaV + HAstV 3 (1) 2 (2) 0 (0)
SaV + RV 2 (0) 0 (0) 0 (0)
SaV + Bacteria 2 (0) 0 (0) 5 (2)
HAstV + RV 1 (0) 0 (0) 0 (0)
HAstV + Bacteria 4 (1) 1 (1) 5 (2)
RV + Bacteria 6 (1) 3 (3) 9 (3)
No pathogens detected, no. (%) 209 (43) 33 (33) 100 (36)
NoV: norovirus; SaV: sapovirus; HAstV: astrovirus; RV: rotavirus.
There were 19 specimens that lacked bacteria and/or rotavirus testing, and they are included in the table as bacteria negative and/or rotavirus negative.
Data from two study sites are combined in this table.
a Uncomplicated diarrhea is defined as three or more loose stools within a 24-hour period, without signs or symptoms of dehydration or dysentery.
b Complicated diarrhea is diarrhea with dehydration, which was defined as drinking eagerly, being unable to drink or breastfeed, emesis, slow capillary
refill (two seconds or more), irritability, sunken eyes, lethargy or unconsciousness.
c Dysentery is defined as reported or visible blood in one or more stool within 24 hours of clinic visit.
doi:10.1371/journal.pone.0145943.t002
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The overall healthcare seeking rate for acute diarrheal illness (PMC) was lower in Lwak (27%)
versus Kibera (47%) and decreased as age increased in both sites (Tables 4 and 5). By adjusting
the outpatient incidence rates by PMC, the overall community incidence rates per 100,000 PYO of
all viruses were found to be higher in Lwak (norovirus: 9,635; sapovirus: 1,445; astrovirus: 3,051)
than in Kibera (norovirus: 4,116; sapovirus: 879; astrovirus: 440). Overall, the community inci-
dence rates of all viruses were the highest among children aged<24 months and decreased as
age increased (Fig 3B). In Kibera, the community incidence of all viruses were low among people
aged5 years, but an increase in norovirus was observed among people aged50 years.
Discussion
To our knowledge, this is the first study to estimate the outpatient and community incidence
rates of norovirus, sapovirus, and astrovirus-associated diarrheal illnesses across the whole age
Table 3. Clinical profile of diarrheal patients by etiology, Kenya.
Norovirus Sapovirus Astrovirus
(n = 156) (n = 20) (n = 22)
No. (%) No. (%) No. (%)
Type of diarrhea
Uncomplicated Diarrheaa 102 (65) 9 (45) 12 (55)
Complicated Diarrheab 23 (15) 4 (20) 6 (27)
Dysenteryc 31 (20) 7 (35) 4 (18)
Diarrhea duration (days)
1–4 134 (86) 12 (60) 17 (77)
5 10 (6) 4 (20) 1 (5)
6 12 (8) 4 (20) 4 (18)
Maximum number of stools in 24 hoursd
1–3 5 (9) 2 (33) 0 (0)
3–10 49 (89) 4 (67) 5 (100)
11 1 (2) 0 (0) 0 (0)
Vomit
Yes 41 (35) 5 (42) 7 (35)
No 77 (65) 7 (58) 13 (65)
Maximum temperature (°C)
37.0 117 (76) 15 (75) 13 (59)
37.1–38.4 26 (17) 3 (15) 6 (27)
38.5–38.9 4 (3) 0 (0) 1 (5)
39.0 6 (4) 2 (10) 2 (9)
Dehydration
Yes 23 (15) 4 (20) 6 (27)
No 133 (85) 16 (80) 16 (73)
Patients with multiple enteric viruses were excluded from the table.
Data from two study sites are combined in this table.
a Uncomplicated diarrhea is defined as three or more loose stools within a 24-hour period, without signs or symptoms of dehydration or dysentery.
b Complicated diarrhea is diarrhea with dehydration, which was defined as drinking eagerly, being unable to drink or breastfeed, emesis, slow capillary
refill (two seconds or more), irritability, sunken eyes, lethargy or unconsciousness.
c Dysentery is defined as reported or visible blood in one or more stool within 24 hours of clinic visit.
d The data on maximum number of stool specimens was not available for Lwak.
doi:10.1371/journal.pone.0145943.t003
Norovirus, Sapovirus, and Astrovirus in Kenya

























































































































































































































































































































































































































































































































































































































































































































































































































































































Norovirus, Sapovirus, and Astrovirus in Kenya



































































































































































































































































































































































































































































































































































































































































































































































































































Norovirus, Sapovirus, and Astrovirus in Kenya





































































































































































































































































































































































































Norovirus, Sapovirus, and Astrovirus in Kenya




















































































































































































































































































































































































































































































































































































































































































































































































































































































Norovirus, Sapovirus, and Astrovirus in Kenya



















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Norovirus, Sapovirus, and Astrovirus in Kenya
PLOS ONE | DOI:10.1371/journal.pone.0145943 April 26, 2016 14 / 20
spectrum in Africa. Our analysis demonstrated a substantial disease burden imposed by these
viruses in both rural and urban Kenya. Norovirus had the highest incidence rates in both sites.
In addition, sapovirus and astrovirus, for which epidemiological data remain limited globally,
were also found to be of considerable disease burden in Kenya. The combination of household
surveillance and clinic surveillance enabled us to identify patients with diarrhea in the study
sites comprehensively, and provided robust estimates of incidence at the outpatient and com-
munity levels by adjusting for the proportion of patients that were missed at the study clinics.
These adjustments revealed the total community burden of disease associated with each virus,
which could not have been observed from the crude incidence rates alone. For example, the
overall crude incidence of norovirus was about same in Kibera than in Lwak, but the overall
outpatient and community incidence rates were calculated to be about 1.4 and 2.3-fold higher
in Lwak than in Kibera, respectively. These findings demonstrated the importance of assessing
healthcare seeking behaviors and access to care issues in the context of surveillance studies for
disease burden estimates. We did not detect an apparent or consistent trend in seasonality at
either study site. Both study sites have two rainy seasons (fromMarch to May and from Octo-
ber to November) [15], but no viruses at either of the sites peaked during both rainy seasons.
According to the 2009 census, there were 26.1 million and 12.5 million people of all ages liv-
ing in rural and urban Kenya, respectively [23]. By applying the adjusted incidence rates in
Lwak to the population in rural Kenya and those in Kibera to the population in urban Kenya,
Fig 2. Annualized crude incidence rates of enteric viruses per 100,000 PYO bymonth, Lwak and Kibera, Kenya.NoV: norovirus; SaV: sapovirus;
HAstV: astrovirus; PYO: person-years of observation. Study period was from June 2007 to October 2008 in Lwak and from October 2006 to February 2009 in
Kibera. Data in the samemonths were combined together and annualized crude incidence rates per 100,000 PYO in each month were calculated as follows:
Average number of positive specimens in each month
PYO
 12 100; 000:
doi:10.1371/journal.pone.0145943.g002
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Fig 3. Adjusted outpatient (A) and community (B) incidence rates of enteric viruses per 100,000 PYO by age group, Lwak and Kibera, Kenya.NoV:
norovirus, SaV: sapovirus, HAstV: astrovirus; PYO: person-years of observation. The outpatient incidence was calculated by dividing the crude incidence by
the proportion of patients who submitted stool specimen among all diarrhea patients meeting stool-sampling criteria (PSS) and the proportion of diarrhea
patients who visited the study clinic among diarrhea patients who visited any clinics including non-study clinics (PSC). The community incidence was
calculated by dividing the outpatient incidence by the proportion of diarrhea patients who visited any clinics among all diarrhea patients identified in the
community, including those who did not seek medical care (PMC).
doi:10.1371/journal.pone.0145943.g003
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we estimate that each year, about 2.8–3.3 million, 0.45–0.54 million, and 0.77–0.95 million peo-
ple across all ages in Kenya become ill with diarrheal illness in the presence of norovirus, sapo-
virus, and astrovirus, respectively. Of these, approximately 0.85–1.0 million, 0.14–0.17 million,
and 0.22–0.27 million people of all ages with norovirus, sapovirus, and astrovirus-associated
diarrheal illnesses seek outpatient care each year in Kenya, respectively. These extrapolations
are based on the assumption that the incidence estimated in the single rural and urban study
sites reflect the incidence in all rural and urban areas of Kenya, respectively. This assumption
may not be appropriate especially for urban areas where the population size is not stable
because of frequent movement in and out of the area. Due to this assumption and other limita-
tions discussed later, these extrapolations may not yield precise national estimates. Nonethe-
less, the magnitude of these estimates suggests the significant burden of these enteric viruses on
the people and healthcare system in Kenya and the importance of targeted public health inter-
ventions for these enteric viruses. Compared to the outpatient incidence of rotavirus estimated
in the same sites among children aged<5 years from 2007 to 2010 (before introduction of rota-
virus vaccine into the national immunization program in 2014) [14], the outpatient incidence
of norovirus was estimated to be 10% higher in Lwak and 46% higher in Kibera among the
same age group. Among the total population across all age groups, the outpatient incidence of
norovirus was about 2-fold higher than that of rotavirus in both sites. Although rotavirus was
detected by enzyme immunoassay in the previous study, which is less sensitive than RT-PCR,
these findings suggest that norovirus is comparably or even more prevalent than rotavirus
among diarrhea patients in the outpatient setting. As diarrheal disease caused by rotavirus
decreases with the introduction of rotavirus vaccines [24, 25], the relative burden of norovirus
is expected to increase in the future.
Comparison of our study findings with similar studies conducted in developed countries
reveals consistent trends and key differences. For example, the estimated community incidence
rates of norovirus disease per 100,000 population across all age groups was 6,500–7,000 in the
U.S. [26–28], 3,800 in the Netherlands [29], and 4,500–4,700 in the United Kingdom [30, 31].
Although these estimates were computed by various methods, rates of norovirus-associated
diseases appear to be 1.2–2.1-fold higher in Kenya compared to those in developed countries.
With regard to adjustment factors for healthcare utilization, the rate of stool specimen submis-
sion was low (5–11%) among younger children and was the highest (21–26%) among patients
aged 18–49 years in both sites in Kenya (Table 3). This is contrary to a previous study’s obser-
vation in the U.S., where young children and the elderly were more likely to submit stool speci-
mens and only less than 1% of patients aged 16–25 years provided specimens [28]. This
observation highlights the importance of obtaining the site specific adjustment factors in order
to estimate an outpatient and community incidence of diseases.
An important limitation of this study is the lack of non-diarrheal or healthy control speci-
mens. As such, we were not able to adjust the attributable fraction to account for asymptomatic
viral detection, as has been done previously [14]. However, we conservatively limited our inci-
dence estimates for norovirus, sapovirus, and astrovirus to only include diarrhea patients that
were not positive for another known pathogen (i.e., enteric bacteria or rotavirus), providing
some reassurance that these were etiologic detections. Other studies have detected these viruses
more frequently in specimens collected from cases compared to those from controls, suggesting
that these three viruses are indeed etiologic causes of diarrheal illnesses [32–34]. It should be
also noted that specimens were not tested for other causes of diarrhea, such as parasites and
adenovirus. Although norovirus was detected as a single pathogen in 11% of dysentery cases,
these cases may have been caused by other pathogens that were not tested in our study or may
represent false negatives of the bacteria testing. There is also a potential that the clinic surveil-
lance missed patients with mild diarrhea, because we did not collect stool specimens from all
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patients who experienced uncomplicated diarrhea. As norovirus is known to more often cause
less severe diarrhea, some cases with norovirus-associated uncomplicated diarrhea were likely
missed at the study clinics, possibly causing an underestimation of our incidence rates. Another
potential limitation is selection bias among patients that submitted stool specimens and sought
medical care at the study clinics, which would limit the representativeness of the data on viral
detection from stools. In addition, because our study periods were not a set on full calendar
years, there is potential for seasonal bias; however, our study was performed for at least one full
calendar year in both sites and our analysis showed there was no clear seasonality in either site.
In conclusion, our study is the first to provide population-based incidence estimates of diar-
rheal illness associated with norovirus, sapovirus, and astrovirus across the age spectrum in
Kenya, and one of the few studies providing such estimates worldwide. The substantial disease
burden of norovirus, which is comparable to that of rotavirus, underscores the potential value
of targeted interventions, such as vaccines, to reduce the health burden of norovirus. Data from
our study can inform cost-effectiveness of potential vaccines against norovirus and help define
a public health strategy for controlling these enteric viruses in developing countries.
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